This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: National Institute of Health and Medical Research. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Jammoul Firas: Innovator in Anticonvulsive Pharmaceutical Compositions
Introduction
Jammoul Firas is a notable inventor based in Bagneux, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anticonvulsive compositions. His work focuses on enhancing the efficacy and safety of treatments that involve GABA receptor activation.
Latest Patents
Firas holds a patent for "Anticonvulsive pharmaceutical compositions." This patent details the use of substances selected from taurine, its precursors, metabolites, derivatives, and analogs. The invention aims to prevent or inhibit undesirable side effects caused by active ingredients that induce high levels of extracellular GABA or increase GABA receptor activation. The pharmaceutical composition includes both the selected substance and the active ingredient, showcasing Firas's innovative approach to addressing complex medical challenges. He has 1 patent to his name.
Career Highlights
Jammoul Firas is affiliated with the National Institute of Health and Medical Research, where he conducts research and develops new pharmaceutical solutions. His work is characterized by a commitment to improving patient outcomes through innovative drug formulations.
Collaborations
Firas collaborates with esteemed colleagues in his field, including Serge Picaud and Jose-Alain Sahel. These partnerships enhance the research and development process, allowing for a multidisciplinary approach to tackling medical issues.
Conclusion
Jammoul Firas is a pioneering inventor whose work in anticonvulsive pharmaceutical compositions has the potential to significantly impact the medical field. His dedication to innovation and collaboration underscores the importance of research in developing effective treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
